Drugs / Lactate, Sodium
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06110429 | Jan 2024 → Jun 2025 | intracranial hypertension | University Hospital, Geneva | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lactate, Sodium | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06110429 ↗ |
| Known as | Sodium lactate | “100 mL of Sodium lactate (Osmolality 2560 mOsm/L) in 15 mins of administration via a central venous catheter” NCT06110429 ↗ |
| Route | Intravenous | “via a central venous catheter” NCT06110429 ↗ |